WHO ICTRP trial

Clinical study of different concentration ropivacaine in intercostal nerve block…

ChiCTR2200057739 · Chinese Clinical Trial Registry (ChiCTR) · Not Recruiting

Key facts

Trial ID ChiCTR2200057739
Public title Clinical study of different concentration ropivacaine in intercostal nerve block in single-port thoracoscopic lobectomy
Scientific title Clinical study of different concentration ropivacaine in intercostal nerve block in single-port thoracoscopic lobectomy
Primary sponsor First Affiliated Hospital of Anhui Medical University
Registry Chinese Clinical Trial Registry (ChiCTR)
Recruitment status Not Recruiting
Study type Interventional study
Phase 0
Countries China
Interventions control group:normal saline intercostal nerve block;ropivacaine group 1:2% ropivacaine intercostal nerve block;ropivacaine group 2:3% ropivacaine intercostal nerve block;ropivacaine group 3:4% ropivacaine intercostal nerve block
Registration date Mar 16, 2022
Target size control group:30;ropivacaine group 1:30;ropivacaine group 2:30;ropivacaine group…
Registry page chictr.org.cn

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations